Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Èíôåêöèîííûå áîëåçíè > Ãåïàòèòû

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 02.03.2018, 20:00
novosibirsk74 novosibirsk74 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 25.02.2018
Ãîðîä: íîâîñèáèðñê
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 1
novosibirsk74 *
Ñïàñèáî,ïî÷èòàþ.À ìîæåò ãåìîãëîáèí ñíèæàòüñÿ íà ôîíå ïðè¸ìà îáåçáàëèâàþùèõ ñðåäñòâ òèïà Íàéñ? (ïðîñòî áûëà îäíà èç âåðñèé âðà÷åé)ïðèíèìàë â òå÷åíèè ãîäà????
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 02.03.2018, 20:07
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ìîæåò, åñëè èõ ïðèåì âûçâàë åðîçèðîâàíèå ÆÊÒ è ÷åðåç åðîçèè òåðÿëîñü 3-5 ìë êðîâè â ñóòêè

NSAID-associated fecal blood loss

The administration of nonsteroidal anti-inflammatory drugs (NSAIDs) is known for its association with upper and lower GI injury. This injury can include bleeding which may be severe enough to result in hospitalization. Even low dose aspirin as well as non-aspirin-NSAIDs increase mean fecal blood loss from roughly 0.5 mL/d to 1-2 mL/d (i.e., 0.5-1.0 mg iron loss/d). Among patients treated with aspirin doses ≥ 1800 mg/d, 31% had a blood loss of ≥ 5 mL/d (i.e., ≥ 2.5 mg iron loss/d). Although cyclooxygenase-2 (COX-2) inhibitors are associated with fewer GI injuries than traditional NSAIDs, long-term use of a COX-2 inhibitor may also induce GI injuries and require concomitant medication for associated anemia and small intestinal injuries. Notably, routine endoscopic examination may not reveal NSAID-induced GI injuries.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 02.03.2018, 20:34
novosibirsk74 novosibirsk74 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 25.02.2018
Ãîðîä: íîâîñèáèðñê
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 1
novosibirsk74 *
Àíàëèç íà ñêðûòóþ êðîâü íå âûÿâèë êðîâîïîòåðþ,à ôãñ ïîêàçàë òîëüêî âàðèêîç ïèùåâîäà. Âû ñ÷èòàåòå,÷òî íóæíî äåëàòü êîëîíîñêîïèþ? Ìåíÿ ÆÊÒ íå áåñïîêîèò íèêàê.
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 02.03.2018, 20:44
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
òîãäà Âàì â ïåðâóþ î÷åðåäü èñêëþ÷àòü íèæåñëåäóþøåå
Causes not associated with bleeding were found in 36 patients (51%), including
19 with atrophic gastritis,
4 with celiac disease, and
13 with Helicobacter pylori gastritis.
âàðèêîç âåí ïèøåâîäà áûâàåò ïðè çàáîëåâàíèÿõ ïå÷åíè, â òîì ÷èñëå è àññîöèèðîâàííûõ ñ öåëèàêèåé
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 02.03.2018, 21:00
novosibirsk74 novosibirsk74 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 25.02.2018
Ãîðîä: íîâîñèáèðñê
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 1
novosibirsk74 *
Òàê ó ìåíÿ ãåïàòèò C è ôèáðîñêàí F-4.Íà÷àëè ëå÷èòü àíåìèþ,à âûÿâèëè ãåïàòèò Ñ. áîëüíèöå ñòàâèëè äèàãíîç, õðîíè÷åñêèé ãàñòðèò â íå îáîñòðåíèè .
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 02.03.2018, 21:20
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìíå ýòî èçâåñòíî, ôðàçà "õðîíè÷åñêèé ãàñòðèò â íå îáîñòðåíèè" â ìåäèöèíå ïî ñìûñëó ïðèìåðíî êàê "ïàðåíü õîòü êóäà"; åñëè òåîðåòè÷åñêè ó Âàñ öåëèàêèéíàÿ àíåìèÿ è öåëèàêèéíîå ïîðàæåíèå ïå÷åíè, òî äàæå åñëè Âû èçëå÷èòå ñâîé ãåïàòèò Ñ, òî ïîëîæèòåëüíûõ èçìåíåíèé â ôóíêöèè ïå÷åíè ìîæåò è íå áûòü (áóäåò ïðîãðåññèðîâàòü öèððîç), ïîêà íå óñòðàíèòå öåëèàêèþ, ïîýòîìó Âàì ñåé÷àñ æèçíåííî âàæíî èñêëþ÷èòü öåëèàêèþ ñ ãðàìîòíûì ãàñòðîýíòåðîëîãîì.

Êîììåíòàðèè ê ñîîáùåíèþ:
easl îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 02.03.2018, 21:24
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,358
Ïîáëàãîäàðèëè 33,212 ðàç(à) çà 31,562 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
÷èòàéòå âñå ïî ññûëêå, âêëþ÷àÿ íèæåèçëîæåííîå

"×àñòîòà öåëèàêèè ó áîëüíûõ ãåïàòèòîì Ñ ñîñòàâëÿåò 1,2–
1,3%, ÷òî ïðåâûøàåò åå ðàñïðîñòðàíåííîñòü â ïîïóëÿöèè.
Îïèñàíû ñëó÷àè ïðåðûâàíèÿ ïðîòèâîâèðóñíîé òåðàïèè èç-çà
ìàíèôåñòàöèè öåëèàêèè òÿæåëîé äèàðååé. Ëå÷åíèå âîçîá-
íîâëÿëè ïîñëå íîðìàëèçàöèè ñòóëà ñ ïîìîùüþ àãëþòåíîâîé
äèåòû. Â ñâÿçè ñ ýòèì îáñóæäàåòñÿ âîïðîñ î íåîáõîäèìîñòè
òåñòèðîâàíèÿ íà öåëèàêèþ áîëüíûõ õðîíè÷åñêèì ãåïàòèòîì
Ñ, êîòîðûì ïðåäñòîèò ïðîòèâîâèðóñíàÿ òåðàïèÿ [20]."
ÖÅËÈÀÊÈß È ÏÀÒÎËÎÃÈß ÏÅ×ÅÍÈ
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 03.03.2018, 18:47
novosibirsk74 novosibirsk74 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 25.02.2018
Ãîðîä: íîâîñèáèðñê
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 1
novosibirsk74 *
Ñïàñèáî,îáÿçàòåëüíî ïðîêîíñóëüòèðóþñü è ó ãåìàòîëîãà,ó êîòîðîãî íàáëþäàþñü è ó ãàñòðîýíòåðîëîãà.È åù¸ èç èñòîðèè ìîåé áîëåçíè,ìåíÿ îøèáî÷íî ïî÷òè ãîä ëå÷èëè îò ãðèáêà âìåñòî ïñîðèàçà è òîëüêî óñóãóáèëè ïðîáëåìó ,äà è åù¸ îäèí óäàð ïî ïå÷åíè.À äðóãîé âðà÷ äèàãíîñöèðîâàë ïñîðèàç.×åñíî ãîâîðÿ íà êàêîãî âðà÷à ïîïàä¸øü,ñòðàøíîâàòî
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 07:19.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.